Senior Director, Strategic Finance

Company Summary

Flagship Labs 97 Inc. (FL97) is a privately held, early-stage technology company pioneering the application of artificial intelligence to transform every aspect of the scientific method. FL97 is backed by Flagship Pioneering, which brings the courage, long-term vision, and resources needed to realize unreasonable results. Join our mission-driven team and contribute to the future of science.

Our Physical Sciences effort is developing a novel AI and data-driven approach to materials discovery and development to accelerate the transition to a sustainable economy.

At FL97, we are uniquely cross-functional and collaborative. We are actively reimagining the way teams work together and communicate. Therefore, we seek individuals with an inclusive mindset and a diversity of thought. Our teams thrive in unstructured and creative environments. All voices are heard because we know that experience comes in many forms, skills are transferable, and passion goes a long way.

If this sounds like an environment you’d love to work in, even if you only have some of the experience listed below, please apply.

Role:

We are seeking an exceptional Senior Director, Strategic Finance, to lead the development and implementation of quantitative frameworks for 5-year planning and capital allocation to guide strategic investments across the company. Key responsibilities include driving FL97’s forecasting process via a detailed projection model, being a central figure in communicating company strategy quantitatively and collaborating closely with several teams to ensure that resource allocation and value creation are tightly coordinated. The role will exist in Lila's Business Operations section, eventually reporting to the CFO but working closely with the CCO, Materials, in the interim.

Outcomes 

Framework Development and Planning

1. Develop a 5-year plan framework for Lila's businesses.
2. Establish a quantitative framework for capital allocation between platform and product investments that will be updated regularly per company operating rhythm.
3. Establish a strong partnership with CCO, CPO, and Senior Accounting leaders to design commercialization and investment frameworks to ensure value creation is realized on both a cash and GAAP basis.

Financial Modeling and Analysis

1. Become the owner and loving parent of the Lila Projection model, including diligencing all inputs and providing curated outputs to aid in strategic discussions.
2. Own the financial model for fundraises, including supporting investor requests as needed.
3. Participate actively in the New Product Introduction (NPI) Process to develop financial models to support introducing new programs and projects.
4. Assist in translating the Projection Model to an annual budget for spending decisions.
5. Own scenario analysis to support budget allocations.

Reporting and Presentations

1. Prepare board and investor materials.
2. Present the forward outlook at Rolling Operational Planning Reviews (ROPRs).
3. On an interim basis, until a more formal Investor Relations capability is built, be the central point of contact for all investor diligence or relations requests.

Collaboration and Partnership

1. Establish a strong partnership with FP&A to create a shared understanding and cross-finance ownership to maximize the use of or address shortcomings in changes in resource requirements.
2. Assist fundraising efforts by completing various tasks associated with capital formation.

Qualifications

• Advanced degree in Finance, Management, or a related field.
• Proven experience in similar roles at early-stage or growth-stage companies.
• Strong strategic thinking, leadership, and communication skills.
• Ability to work in a fast-paced, ambiguous environment.
• Experience with AI and machine learning is a plus.

About Flagship

Flagship Pioneering is a bioplatform innovation company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures, resulting in more than $90 billion in aggregate value. Many of the companies Flagship has founded have addressed humanity’s most urgent challenges: vaccinating billions of people against COVID-19, curing intractable diseases, improving human health, preempting illness, and feeding the world by improving the resiliency and sustainability of agriculture.  Flagship has been recognized twice on FORTUNE’s